Home
>
National Drug Code (NDC)
>
Starlix
Starlix - 0078-0352-05 - (nateglinide)
Drug Information of Starlix
| Product NDC: | 0078-0352 |
| Proprietary Name: | Starlix |
| Non Proprietary Name: | nateglinide |
| Active Ingredient(s): | 120 mg/1 & nbsp; nateglinide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Starlix
| Product NDC: | 0078-0352 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021204 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20001204 |
Package Information of Starlix
| Package NDC: | 0078-0352-05 |
| Package Description: | 100 TABLET in 1 BOTTLE (0078-0352-05) |
NDC Information of Starlix
| NDC Code | 0078-0352-05 |
| Proprietary Name | Starlix |
| Package Description | 100 TABLET in 1 BOTTLE (0078-0352-05) |
| Product NDC | 0078-0352 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | nateglinide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20001204 |
| Marketing Category Name | NDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | NATEGLINIDE |
| Strength Number | 120 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Glinide [EPC],Potassium Channel Antagonists [MoA] |
